Mobarakeh Steel Industries in Isfahan was struck for the second time in a week on 1 April, killing one worker and wounding 15, while the IDF struck the Tofiq Daru pharmaceutical factory in Tehran claiming it supplied fentanyl for chemical weapons research. The third Bushehr strike had established the pattern of striking sensitive facilities with contested dual-use claims; the Tofiq Daru strike follows that template.
The IDF's claim about Tofiq Daru is specific: the factory supplied fentanyl to SPND, the Defence Ministry's weapons development agency, for chemical weapons research. Iran said it manufactured hospital drugs. Both may be true. The IRGC's documented willingness to use civilian industrial facilities for dual-purpose operations is established; whether this specific factory falls within that pattern is not determinable from open sources.
What is determinable is the precedent: a pharmaceutical factory serving civilian hospitals has been struck on a chemical weapons justification, with no international mechanism to verify the claim before or after the strike. Nine hospitals had already gone dark and over 300 health sites were damaged before today's strike. Araghchi's 'war criminals' language will be used for maximum international sympathy, following the same trajectory as the cluster warhead strike on three Israeli cities that drew mutual war crimes accusations.
Mobarakeh Steel's second strike in a week, along with a simultaneous hit on Khuzestan Steel in Ahvaz with no casualties, demonstrates systematic degradation of Iran's steel production capacity. Steel feeds both civilian construction and military manufacturing; the targeting cycle suggests a deliberate campaign against industrial output rather than isolated military strikes.
